baicalin has been researched along with alpha-chymotrypsin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, W; Miura, N; Sato, E; Wu, YX | 1 |
1 other study(ies) available for baicalin and alpha-chymotrypsin
| Article | Year |
|---|---|
Baicalin and scutellarin are proteasome inhibitors that specifically target chymotrypsin-like catalytic activity.
Topics: Animals; Apigenin; Apoptosis; Cell Line, Tumor; Cell Survival; Chymotrypsin; Erigeron; Female; Flavonoids; Glucuronates; Humans; Liver; Mice; Mice, Inbred ICR; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Scutellaria baicalensis | 2013 |